Form 3 - Initial statement of beneficial ownership of securities
15 August 2024 - 12:19AM
Edgar (US Regulatory)
Exhibit 24.1
POWER OF ATTORNEY
Know all by these presents, that the undersigned
hereby constitutes and appoints each of Jaime Bartushak, Alexander M. Donaldson, and Lorna A. Knick, and each of them acting alone, signing
singly, the undersigned’s true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned’s
capacity as an officer, director and/or 10% or more stockholder of Citius Oncology, Inc. (the “Company”), Forms ID, 3, 4 and
5, Update Passphrase Acknowledgement (and any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934,
as amended (the “1934 Act”) and Schedules 13D and/or Schedules 13G (and any amendments thereto) in accordance with the 1934
Act, and the rules promulgated thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary
or desirable to complete and execute any such Forms ID, 3, 4 and 5, Update Passphrase Acknowledgement and Schedules 13D and/or Schedules
13G (and any amendments thereto) and to file timely such form with the United States Securities and Exchange Commission and any stock
exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which in the opinion
of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood
that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such
form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.
The undersigned hereby grants to each such attorney-in-fact
full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally
present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s
substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned,
are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the 1934 Act.
This Power of Attorney shall remain in full force
and effect until the undersigned is no longer required to file Forms ID, 3, 4 and 5 and Schedules 13D and/or Schedules 13G with respect
to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned, in a
signed writing delivered to each of the foregoing attorneys-in-fact.
The undersigned attests and
agrees that the use of an electronic signature in any authentication document that includes the undersigned signatory’s typed, conformed
signature, and that is filed with or furnished to the Commission by or on behalf of the undersigned signatory, the Company or any of its
affiliates, constitutes the legal equivalent of the undersigned signatory’s manual signature for purposes of authenticating the
undersigned signatory’s signature to any filing or submission for which it is provided.
IN WITNESS WHEREOF, the undersigned has caused
this Power of Attorney to be executed as of this 13th day of August 2024.
|
CITIUS
PHARMACEUTICALS, INC. |
|
|
|
/s/
Leonard Mazur |
|
Leonard
Mazur, CEO |
Citius Pharmaceuticals (NASDAQ:CTXR)
Historical Stock Chart
Von Sep 2024 bis Okt 2024
Citius Pharmaceuticals (NASDAQ:CTXR)
Historical Stock Chart
Von Okt 2023 bis Okt 2024